AML

Predicting outcomes in therapy-related AML

April 22, 2021

Sequential Targeted Treatment for a Geriatric Patient with Acute Myeloid Leukemia with Concurrent FLT3-TKD and IDH1 Mutations

January 7, 2021

Black race linked to poorer survival in AML

December 10, 2020

Beat AML: Precision medicine strategy feasible, superior to SOC for AML

November 10, 2020

Novel agents hold promise for frontline AML treatment

October 28, 2020

Survey quantifies COVID-19’s impact on oncology

September 20, 2020

First-in-kind anti-CD47 antibody shows promise for MDS and AML treatment

June 19, 2020

AML

Risk index stratifies pediatric leukemia patients undergoing HSCT

June 8, 2020

Survival for older AML patients better with HSCT from unrelated donors

February 8, 2020

AML

9/11 responders show increased risk of leukemia, other cancers

January 14, 2020

Kidney function in African American AML patients not linked to reduced survival compared with whites

December 7, 2019

AML

Will TP53-mutated AML respond to immunotherapy?

November 18, 2019

Adverse cytogenetics trump molecular risk in NPM1-mutated AML

October 15, 2019

For tough AML, half respond to selinexor plus chemotherapy

June 25, 2019

AML

Researchers propose new risk groups for NK-AML

May 8, 2019